Showing results (1191-1200 of 2,865) with videos related to

Sort By:
Pageof 287
JACC. Cardiovascular Interventions|January 15, 2016
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled TrialsUsman Baber, Gennaro Giustino, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|January 15, 2016
Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) StudyThierry Lefèvre, Antonio Colombo, Didier Tchétché, et al.
JACC. Cardiovascular Interventions|January 19, 2016
Immediate Versus Delayed Invasive Intervention for Non-STEMI Patients: The RIDDLE-NSTEMI StudyAleksandra Milosevic, Zorana Vasiljevic-Pokrajcic, Dejan Milasinovic, et al.
JACC. Cardiovascular Interventions|January 19, 2016
Randomized Comparison of Different Thienopyridine Loading Strategies in Patients Undergoing Elective Coronary Intervention: The ExcelsiorLOAD TrialWillibald Hochholzer, Michael Amann, Alexander Titov, et al.
JACC. Cardiovascular Interventions|January 3, 2016
Effects of Mechanical Ventilation on Heart Geometry and Mitral Valve Leaflet Coaptation During Percutaneous Edge-to-Edge Mitral Valve RepairJohannes Patzelt, Yingying Zhang, Peter Seizer, et al.
JACC. Cardiovascular Interventions|January 8, 2016
The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data RegistryLuis Gruberg, Anne S Hellkamp, Laine E Thomas, et al.
JACC. Cardiovascular Interventions|January 8, 2016
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)Ajay J Kirtane, Puja B Parikh, Thomas D Stuckey, et al.
JACC. Cardiovascular Interventions|February 16, 2016
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA RegistriesCorrado Tamburino, Piera Capranzano, Tommaso Gori, et al.
JACC. Cardiovascular Interventions|January 23, 2016
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting StentsJames B Hermiller, Mitchell W Krucoff, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|December 16, 2014
Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trialStephan Blazek, Cornelius Rossbach, Michael A Borger, et al.
Pageof 287